Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-02-17

Clinical Trial Update: Use of Gadolinium in CT Pulmonary Angiography [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating gadolinium use in CT pulmonary angiography has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pulmonary Embolism | Phase 4 | Status: WITHDRAWN